Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Journal of Immunology Research|November 29, 2017
CD80 Expressed by CD8+ T Cells Contributes to PD-L1-Induced Apoptosis of Activated CD8+ T CellsMeagan R Rollins, Rachel M Gibbons JohnsonCurrent Protocols in Immunology|May 21, 2020
T Cell Receptor Engineered Lymphocytes for Cancer TherapyMeagan R Rollins, Ellen J Spartz, Ingunn M StromnesThe Journal of Biological Chemistry|July 19, 2018
GRK2 mediates TCR-induced transactivation of CXCR4 and TCR-CXCR4 complex formation that drives PI3Kγ/PREX1 signaling and T cell cytokine secretionBrittney A Dinkel, Kimberly N Kremer, Meagan R Rollins, et al.Journal for Immunotherapy of Cancer|February 25, 2022
Insufficiency of compound immune checkpoint blockade to overcome engineered T cell exhaustion in pancreatic cancerIngunn M Stromnes, Ayaka Hulbert, Meagan R Rollins, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 9, 2021
CD40 Agonist Overcomes T Cell Exhaustion Induced by Chronic Myeloid Cell IL-27 Production in a Pancreatic Cancer Preclinical ModelAdam L Burrack, Meagan R Rollins, Ellen J Spartz, et al.Cancer Immunology, Immunotherapy : CII|December 6, 2022
Cxcr3 constrains pancreatic cancer dissemination through instructing T cell fateAdam L Burrack, Ellen J Spartz, Meagan R Rollins, et al.Nature Communications|February 1, 2023
Germline T cell receptor exchange results in physiological T cell development and functionMeagan R Rollins, Jackson F Raynor, Ebony A Miller, et al.JCI Insight|April 8, 2022
Distinct myeloid antigen-presenting cells dictate differential fates of tumor-specific CD8+ T cells in pancreatic cancerAdam L Burrack, Zoe C Schmiechen, Michael T Patterson, et al.Nature Communications|June 24, 2021
Irreversible electroporation augments checkpoint immunotherapy in prostate cancer and promotes tumor antigen-specific tissue-resident memory CD8+ T cellsBrandon J Burbach, Stephen D O'Flanagan, Qi Shao, et al.Pageof 1